Amgen Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Amgen Inc
CIK #0000318154
EDGAR Form CIK 2011 - 2026
10-K [0000318154]
10-Q [0000318154]
3 [0000318154]
4 [0000318154]
5 [0000318154]
8-K [0000318154]
SC 13D [0000318154]
SC 13G [0000318154]
Form 13D/13G Filer Form 13D/13G Subject Filed
Capital World Investors Amgen Inc [2026-05-14]
Vanguard Capital Management LLC Amgen Inc [2026-04-29]
Amgen Inc Neumora Therapeutics Inc [2023-09-27]
Amgen Inc Newamsterdam Pharma Co NV [2022-12-02]
Amgen Inc Vigil Neuroscience Inc [2022-01-12]
Amgen Inc Jasper Therapeutics Inc [2021-10-01]
State Street Corp Amgen Inc [2021-02-05]
Amgen Inc Akero Therapeutics Inc [2020-02-10]
Amgen Inc BeiGene Ltd [2020-01-08]
Amgen Inc Provention Bio Inc [2019-09-25]
View All
Form 3/4/5 Subject 2011 - 2026
Garland Greg C
Amgen Inc
Druker Brian
Drake Michael V
Austin Wanda M
Miles Amy E
Kullman Ellen Jamison
Klotman Mary E
Jacks Tyler
Ishrak Omar
Holley Charles M
Eckert Robert
Reese David M
Busch Matthew C
Bradner James E
Bradway Robert A
Gordon Murdo
Graham Jonathan P
Griffith Peter H
Grygiel Nancy A
Khosla Rachna
Miller Derek
Santos Esteban
Neumora Therapeutics Inc
Sugar Ronald D
Williams R Sanders
Louie Linda H
Johnston Lori A
Vigil Neuroscience Inc
BeOne Medicines Ltd
Piacquad David
Henderson Rebecca M
Hassan Fred
Patton Cynthia M
Meline David W
Herringer Frank C
Harper Sean E
Onyx Therapeutics Inc
Kezar Life Sciences Inc
Hooper Anthony C
de Carbonnel Francois
Baltimore David
Such Annette Louise
McNamee Brian M
Pelham Judith C
Biondi Frank
Tross Stuart A
Balachandran Madhavan
Coffman Vance D
Unilife Corp
Scott David J
Michael A Kelly
Dittrich Thomas JW
Omenn Gilbert S
Amgen Ventures LLC
Tetralogic Pharmaceuticals Corp
Peacock Jonathan M
Epizyme Inc
Schaeffer Leonard D
Reason J Paul
Sharer Kevin W
Richo Anna
Bonanni Fabrizio
Beier David W
Micromet Inc
Armstrong Acquisition Corp
Perlmutter Roger M
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 327 $366.21 119,751
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 6,691 $366.21 2,450,311
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 707 $366.21 258,910
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 5,748 $366.21 2,104,975
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 5,353 $366.21 1,960,322
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 6,022 $366.21 2,205,317
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 1,616 $366.21 591,795
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 5,621 $366.21 2,058,466
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 787 $366.21 288,207
Amgen Inc AMGN
Common Stock
2026-03-16 Tax withheld 21,294 $366.21 7,798,076
Amgen Inc AMGN
Common Stock
2026-03-04 Tax withheld 84,285 $379.27 31,966,772
Amgen Inc AMGN
Common Stock
2026-03-04 Option exercise 119,782 $156.35 18,727,916
Amgen Inc AMGN
Nqso (Right to Buy) · derivative
2026-03-04 Option exercise 119,782 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 10,723 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 3,484 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 12,063 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 11,259 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 2,010 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 13,403 $0.00
Amgen Inc AMGN
Common Stock
2026-03-03 Grant 42,657 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com